N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, announces two operational updates.
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, announces two operational updates.
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to provide a further update on its ongoing
N4 Pharma PLC’s (AIM: N4P) shares have risen by more than 7% following the biotech firm’s announcement that it has successfully completed the single loading of EGFR and BCL-2 siRNA
The good start to life on the stock market this week, buoyed by the bump in cryptos has been backed by director buying.
Overall, it was a decent week for London’s junior markets, with AIM100 up 0.39% to 4,034 though it lagged against the Footsie, which rose more than 0.8%.
Synergia Energy (SYN) announced it has submitted a formal application for its removal from the Official List of the Australian Securities Exchange pursuant to ASX Listing Rule 17.11. This would
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Baron Oil, Bezant Resources,
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Pound/Dollar, Boston International Holdings,
During the week Zak was fortunate enough to bump into a stockbroker who, with more than 30 years in the saddle, can be regarded as one of the leaders in
Zak Mir takes a charting look at some of the small caps stocks of the week on the London stock market. Today’s selection of charts is FTSE 100, Pound /
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Pound / Dollar, Bitcoin,